Inflammation and oxidative stress in gastroesophageal reflux disease

Journal of Clinical Biochemistry and Nutrition

Volumn 40, Issue 1, 2007, Pages 13-23

  Yoshida, Norimasa ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Gastroesophageal reflux disease (GERD); Inflammation; Nonerosive reflux disease (NERD); Oxidative stress; Substance P

Indexed keywords

ALCOHOL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BILE ACID; CAMOSTAT MESILATE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; PROTON PUMP INHIBITOR; SUBSTANCE P; TRANSCRIPTOME; VANILLOID RECEPTOR;

DRUG EFFECT; DRUG INHIBITION; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; HUMAN; INFLAMMATION; LEUKOCYTE; NOCICEPTIVE RECEPTOR; NONHUMAN; OXIDATIVE STRESS; PANCREAS JUICE; REVIEW; STOMACH ACID;

EID: 33947433224     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.40.13     Document Type: Review

References (52)

1. Dimenas, E.: Methodological aspects of evaluation of Quality of Life in upper gastr ointestinal diseases. Scand. J. Gastroenterol. Suppl., 199, 18-21, 1993.
2. Orlando, R.C: Esophageal epithelial resistance. in Gastroesophageal reflux disease: Pathogenesis, Diagnosis, Therapy, eds. By Castell, D.O., Wu, W.C., and Ott, D.J., Futura, Mount Kisco, pp. 55-79, 1985.
3. Yoshida, N. and Yoshikawa, T.: Defense mechanism of the esophageal mucosa and esophageal inflammation. J. Gastroenterol., 38, 31-34, 2003.
4. Yoshida, N., Uchiyama, K., Kuroda, M., Sakuma, K., Kokura, S., Ichikawa, H., Naito, Y., Takemura, T., Yoshikawa, T., and Okanoue, T.: IL-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand. J. Gastroenterol., 39, 816-822, 2004.
5. Yoshida, N., Kuroda, M., Uchiyama, K., Suzuki, T., Okuda, T., Tsuboi, H., Kajikawa, H., Handa, O., Kokura, S., Ichikawa, H., Yoshikawa, T., and Okanoue, T.: Microarray analysis of transcriptome in patients with nonerosive reflux disease. Gastroenterology, 128, A-523, 2005.
6. Isomoto, H., Wang, A., Mizuta, Y., Akazawa, Y., Ohba, K., Omagari, K., Miyazaki, M., Murase, K., Hayashi, T., Inoue, K., Murata, I., and Kohno, S.: Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am. J. Gastroenterol., 98, 551-556, 2003.
7. Fitzgerald, R.C., Onwuegbusi, B.A., Bajaj-Elliott, M., Saeed, I.T., Burnham, W.R., and Farthing, M.J.: Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut, 50, 451-459, 2002.
8. Dobbagh, K., Takeyama, K., Lee, H., Ueki, I.F., Lausier, J.A., and Nadel, J.A.: IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol., 162, 6233-6237, 1999.
9. Colgan, S., Resnick, M., Parkos, C., Delp-Archer, C., McGuirk, D., Bacarra, A.E., Weller, P.F., and Madara, J.L.: IL-4 directly modulates function of a model human intestinal epithelium. J. Immunol., 153, 2122-2129, 1994.
10. Jankowski, J.: Gene expression in Barrett's mucosa: acute and chronic adaptive responses in the oesophagus. Gut, 34, 1649-1650, 1993.
11. Wetscher, G.J., Hinder, R.A., Bagchi, D., Hinder, P.R., Bagchi, M., Perdikis, G., and McGinn, T.: Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am. J. Surg., 170, 552-556, 1995.
12. Olyaee, M., Sontag, S., Salman, W., Schnell, T., Mobarhan, S., Eiznhamer, D., and Keshavarzian, A.: Mucosal reactive oxygen species production in oesophagitis and Barrett's esophagus. Gut, 37, 168-173, 1995.
13. Jimenez, P., Piazuelo, E., Sanchez, M.T., Ortego, J., Soteras, F., and Lanas, A.: Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J. Gastroenterol., 11, 2697-2703, 2005.
14. Sihvo, E.I., Salminen, J.T., Rantanen, T.K., Ramo, O.J., Ahotupa, M., Farkkila, M., Auvinen, M.I., and Salo, J.A.: Oxidative stress has a role in malignant transformation in Barrett's esophagus. Int. J. Cancer, 20, 551-555, 2002.
15. Rantanen, T.K., Rasanen, J.V., Sihvo, E.L., Ahotupa, M.O., Farkkila, M.A., and Salo, J.A.: The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study. Am. J. Gastroenterol., 101, 222-228, 2006.
16. Oksala, N.K., Atalay, M., and Rantanen, T.K.: Antireflux surgery and esophageal mucosal DNA damage. Pathophysiology, 21, 23-27, 2006.
17. Yoshida, N., Imamoto, K., Uchiyama, K., Kuroda, M., Naito, Y., Mukaida, N., Kawabe, A., Shimada, Y., Yoshikawa, T., and Okanoue, T.: Molecular mechanisms involved in IL-8 production by normal human esophageal epithelial cells. Aliment. Pharmacol. Ther. sympo. ser., 2, 219-226, 2006.
18. Yoshida, N., Katada, K., Handa, O., Takagi, T., Kokura, S., Naito, Y., Mukaida, N., Soma, T., Shimada, Y., Yoshikawa, T., and Okanoue, T.: Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int. J. Mol. Med., In press.
19. Jenkins, G.J., Harries, K., Doak, S.H., Wilmes, A., Griffiths, A.P., Baxter, J.N., and Parry, J.M.: The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis, 25, 317-323, 2004.
20. Yamaguchi, T., Yoshida, N., Tomatsuri, N., Takayama, R., Katada, K., Takagi, T., Ichikawa, H., Naito, Y., Okanoue, T., and Yoshikawa, T.: Cytokine-induced neutrophil accumulation in the pathogenesisi of acute esophagitis in rats. Int. J. Mol. Med., 16, 71-77, 2005.
21. Naito, Y., Uchiyama, K., Kuroda, M., Takagi, T., Kokura, S., Yoshida, N., Ichikawa, H., and Yoshikawa, T.: Role of pancreatic trypsin in chronic asphagitis induced by gastroduodenal reflux in rats. J. Gastroenterol., 41, 198-208, 2006.
22. Erbil, Y., Turkoglu, U., Barbaras, U., Balik, E., Olgac, V., Kaya, H., and Cimsit, B.: Oxidative damage in an experimentally induced gastric and gastroduodenal reflux model. Surg. Innov., 12, 219-225, 2005.
23. Wetscher, G.J., Perdikis, G., Kretchmar, D.H., Stinson, R.G., Baguchi, D., Redmand, E.J., Adrian, T.E., and Hinder, R.A.: Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig. Dis. Sci., 40, 1297-1305, 1995.
24. Wetscher, G.J., Hinder, P.R., Bagchi, D., Perdikis, G., Redmand, E.J., Glaser, K., Adrian, T.E., and Hinder, R.A.: Free radical scavengers prevent reflux esophagitis in rats. Dig. Dis. Sci., 40, 1292-1296, 1995.
25. Naya, M.J., Pereboom, D., Ortego, J., Alda, J.O., and Lanas, A.: Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. Gut, 40, 175-181, 1997.
26. Soteras, F., Lanas, A., Fiteni, I., Royo, Y., Jimenez, P., Inarrea, P., Ortego, J., and Esteva, F.: Nitric oxide and superoxide anion in low-grade esophagitis induced by acid and pepsin in rabbits. Dig. Dis. Sci., 45, 1802-1809, 2000.
27. Oh, T.Y., Lee, J.S., Ahn, B.O., Cho, H., Kim, W.B., Kim, Y.B., Surh, Y.J., Cho, S.W., and Hahm, K.B.: Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic. Biol. Med., 30, 905-915, 2001.
28. Lee, J.S., Oh, T.Y., Ahn, B.O., Cho, H., Kim, W.B., Kim, Y.B., Surh, Y.J., Kim, H.J., and Hahm, K.B.: Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: cule for the chemoprevention of esophageal carcinoma by antioxidants. Mutat. Res., 480-481, 189-200, 2001.
29. Chen, X., Ding, Y.W., Yang, G., Bondoc, F., Lee, M.J., and Yang, C.S.: Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis, 21, 257-263, 2000.
30. Piazuelo, E., Cebrian, C., Escartin, A., Jimenez, P., Soteras, F., Ortego, J., and Lanas, A.: Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J. Gastroenterol., 11, 7436-7443, 2005.
31. Cheng, L., Cao, W., Behar, J., Biancani, P., and Harnett, K.M.: Inflammation induced changes in arachidonic acid metabolism in cat LES circular muscle. Am. J. Physiol., 288, G787-797, 2005.
32. Cheng, L., Cao, W., Fiocchi, C., Behar, J., Biancani, P., and Harnett, K.M.: Platelet-activating factor and prostaglandin E2 impair esophageal Ach release in experimental esophagitis. Am. J. Physiol., 289, G418-428, 2005.
33. Cao, W., Harnett, K.M., Cheng, L., Kirber, M.T., Behar, J., and Biancani, P.: H2O2: a mediator of esophagitis-induced damage to calcium-release mechanisms in cat lower esophageal sphincter. Am. J. Physiol., 288, G1170-1178, 2005.
34. Cheng, L., Cao, W., Fiocchi, C., Behar, J., Biancani, P., and Harmett, K.M.: In vitro model of acute esophagitis in the cat. Am. J. Physiol., 289, G860-869, 2005.
35. Cheng, L., Harnett, K.M., Cao, W., Liu, F., Behar, J., Fiocchi, C., and Biancani, P.: Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagus. Gastroenterology, 129, 1675-1685, 2005.
36. Trimble, K.C., Pryde, A., and Heading, R.C.: Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut, 37, 7-12, 1995.
37. Miwa, H., Minoo, T., Hojo, M., Yaginuma, R., Nagahara, A., Kawabe, M., Ohkawa, A., Asaoka, D., Kurosawa, A., Ohkusa, T., and Sato, N.: Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment. Pharmacol. Ther., 20, 112-117, 2004.
38. Yoshida, N.: Progress in study for mechanism of gastric mucosal injury. Nippon Rinsho, 59, 1829-1836, 2001.
39. Yoshida, N., Yoshikawa, T., Tanaka, Y. Fujita, N., Kassai, K., Naito, Y., and Kondo, M.: A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment. Pharmacol. Ther., 14, 74-81, 2000.
40. Wandall, J.H.: Effects of omeprazole on neutrophil chemotaxis, superoxide production, degranulation, and translocation cytochrome b-245. Gut, 33, 617-621, 1992.
41. Suzuki, M., Mori, M., Miura, S., Suematsu, M., Fukumura, D., Kimura, H., and Ishii, H.: Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic. Biol. Med., 21, 727-731, 1996.
42. Hamaguchi, M., Fujiwara, Y., Takashima, T., Hayakawa, T., Sasaki, E., Shiba, M., Watanabe, T., Tominaga, K., Oshitani, N., Matsumoto, T., Higuchi, K., and Arakawa, T.: Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion, 68, 189-197, 2003.
43. Ichikawa, H., Yoshida, N., Takagi, T., Tomatsuri, N., Katada, K., Isozaki, Y., Uchiyama, K., Naito, Y., Okanoue, T., and Yoshikawa, T.: Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. World. J. Gastroenterol., 10, 2814-2817, 2004.
44. Kuroda, M., Yoshida, N., Ichikawa, H., Takagi, T., Okuda, T., Naito, Y., Okanoue, T., and Yoshikawa, T.: Lansoprazole, proton pump inhibitor, reduces the severity of indomethacin-induced rat colitis. Int. J. Mol. Med., 17, 89-93, 2006.
45. Handa, O., Yoshida, N., Fujita, N., Tanaka, Y., Ueda, M., Takagi, T., Kokura, S., Naito, Y., Okanoue, T., and Yoshikawa, T.: Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm. Res., 55, 476-480, 2006.
46. Naito, Y., Yoshikawa, T., Tanigawa, T., Sakurai, K., Yamasaki, K., Uchida, M., and Kondo, M.: Hydroxyl radical scavenging by rebamipide and related compounds: Electron paramagnetic resonance study. Free Radic. Biol. Med., 18, 117-123, 1995.
47. Yoshida, N., Yoshikawa, T., Iinuma, S., Arai, M., Takenaka, S., Sakamoto, K., Miyajima, T., Nakamura, Y., Yagi, N., Naito, Y., Mukai, F., and Kondo, M.: Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig. Dis. Sci., 41, 1139-1144, 1996.
48. Genta, R.M.: Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract. Aliment. Pharmacol. Ther., 18, 8-13, 2003.
49. Katada, K., Yoshida, N., Isozaki, Y., Tomatsuri, N., Ichikawa, H., Naito, Y., Okanoue, T., and Yoshikawa, T.: Prevention of acute reflux esophagitis in rats with rebamipide. Dig. Dis. Sci., 50, 97-103, 2005.
50. Ossovskaya, V.S. and Bunnett, N.W.: Protease-activated receptors: contribution to physiology and disease. Physiol. Rev., 84, 579-621, 2004.
51. Isozaki, Y., Yoshida, N., Kuroda, M., Handa, O., Takagi, T., Kokura, S., Ichikawa, H., Naito, Y., Okanoue, T., and Yoshikawa, T.: Therapeutic effect of anti-tryptase treatment using nafamostat mesilate on inflammatory bowel disease. Scand. J. Gastroenterol., 41, 944-953, 2006.
52. Yoshida, N., Isozaki, Y., Takagi, T., Takenaka, S., Uchikawa, R., Arizono, N., Yoshiakwa, T., and Okanoue, T.: Review article: anti-tryptase therapy in inflammatory bowel disease. Aliment. Pharmacol. Ther. sympo. ser., 2, 249-255, 2006.